Literature DB >> 20016910

Changing causes of enucleation over the past 60 years.

Vikram J Setlur1, Jignesh G Parikh, Narsing A Rao.   

Abstract

BACKGROUND: The indications for enucleation have changed significantly over the past 60 years. We conducted a clinicopathologic study of enucleated globes to determine how and why the indications for enucleation have changed over time.
METHODS: This retrospective review examined the pathology reports for 3,264 enucleated globes submitted to the Doheny Eye Institute between 1950 and 2006. Three years per decade were examined to generate a representative pool of specimens for each decade. Although the data for the 2000s were only available up to 2006, the data for this decade are drawn from 3 sample years as are all other decades. Pathology reports were reviewed for demographic information (age, sex, and ethnicity), clinical history prior to enucleation, and pathologic findings and diagnoses. Specimens were grouped according to the reason for enucleation into the following categories: atrophic/phthisis bulbi, congenital, glaucoma, infection, longstanding retinal detachment, trauma, tumor, uveitis, and other.
RESULTS: During the study period, there were 3,264 enucleated globes. Overall, the total number of enucleations decreased over time from a peak of 1,014 in the 1960s to 275 in the 2000s. Glaucoma was the most common reason for enucleation during the 1950s (23%, 127 globes) and 1960s (31%, 315 globes). However, glaucoma steadily decreased over the following decades, and was responsible for only 8% (23 globes) of enucleations in the 2000s. Neovascular glaucoma (including glaucoma secondary to retinal vein occlusion and diabetic neovascularization) accounted for 21% (27 globes) of enucleations in the 1950s. By the 2000s, this number was 57% (13 globes). Trauma-related glaucoma accounted for 34% (43 globes) of all enucleations due to glaucoma in the 1950s, and 0% (0 globes) in the 2000s. Enucleation of globes with intraocular neoplasms accounted for 14% (79 globes) of total enucleations in the 1950s, 33% (120 globes) in the 1990s, and 51% (141 globes) in the 2000s. Uveal melanoma was the main intraocular neoplasm in the 1950s (77%, 60 globes), and retinoblastoma was the primary tumor in the enucleated globes of the 2000s (69%, 97 globes).
CONCLUSIONS: Improved medical and surgical treatment of conditions that lead to end-stage eye disease have led to a decrease in total enucleated globes. This is particularly evident for glaucoma. Changing demographics in Los Angeles and referral patterns are most likely responsible for the increase in retinoblastoma. The absolute number of enucleations secondary to neoplasms has not decreased over time, despite an increase in globe-conserving treatments such as chemotherapy and radioactive plaques.

Entities:  

Mesh:

Year:  2009        PMID: 20016910     DOI: 10.1007/s00417-009-1262-8

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  16 in total

1.  Review of 1028 bulbar eviscerations and enucleations. Changes in aetiology and frequency over a 20-year period.

Authors:  A B Hansen; C Petersen; S Heegaard; J U Prause
Journal:  Acta Ophthalmol Scand       Date:  1999-06

2.  The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19.

Authors:  Lee M Jampol; Claudia S Moy; Timothy G Murray; Sandra M Reynolds; Daniel M Albert; Andrew P Schachat; Kenneth R Diddie; Robert E Engstrom; Paul T Finger; Kenneth R Hovland; Leonard Joffe; Karl R Olsen; Craig G Wells
Journal:  Ophthalmology       Date:  2002-12       Impact factor: 12.079

3.  Causes for removal of the eye: a study of 890 eyes.

Authors:  J K Lim; A A Cinotti
Journal:  Ann Ophthalmol       Date:  1976-07

4.  [Clinical indications for enucleation in the material of Department of Ophthalmology, Medical Academy in Białystok in the years 1982-2002].

Authors:  Iwona Obuchowska; Nebi Sherkawey; Sulyman Elmdhm; Zofia Mariak; Andrzej Stankiewicz
Journal:  Klin Oczna       Date:  2005

5.  Twenty year review of histopathological findings in enucleated/eviscerated eyes.

Authors:  M U Saeed; B Y P Chang; M Khandwala; A G Shivane; A Chakrabarty
Journal:  J Clin Pathol       Date:  2006-02       Impact factor: 3.411

Review 6.  Current treatment and management of retinoblastoma.

Authors:  Dan S Gombos; And Patricia Chevez-Barrios
Journal:  Curr Oncol Rep       Date:  2007-11       Impact factor: 5.075

7.  Clinicopathological review of 1146 enucleations (1980-90).

Authors:  P de Gottrau; L M Holbach; G O Naumann
Journal:  Br J Ophthalmol       Date:  1994-04       Impact factor: 4.638

8.  Incidence of uveal melanoma in the United States: 1973-1997.

Authors:  Arun D Singh; Allan Topham
Journal:  Ophthalmology       Date:  2003-05       Impact factor: 12.079

9.  Review of 1375 enucleations in the TongRen Eye Centre, Beijing.

Authors:  G Y Cheng; B Li; L Q Li; F Gao; R J Ren; X L Xu; J B Jonas
Journal:  Eye (Lond)       Date:  2007-06-29       Impact factor: 3.775

View more
  16 in total

Review 1.  Ocular prosthesis incorporating IPS e-max press scleral veneer and a literature review on non-integrated ocular prosthesis.

Authors:  Godwin Clovis Da Costa; Meena Ajay Aras; Paul Chalakkal; Michelle Clovis Da Costa
Journal:  Int J Ophthalmol       Date:  2017-01-18       Impact factor: 1.779

2.  Predictive factors of enucleation after open globe injuries.

Authors:  Effy Ojuok; Aditya Uppuluri; Paul D Langer; Marco A Zarbin; Loka Thangamathesvaran; Neelakshi Bhagat
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-06-21       Impact factor: 3.117

3.  The effect of cancer therapies on pediatric anophthalmic sockets.

Authors:  Yevgeniy Shildkrot; Maria Kirzhner; Barrett G Haik; Ibrahim Qaddoumi; Carlos Rodriguez-Galindo; Matthew W Wilson
Journal:  Ophthalmology       Date:  2011-12       Impact factor: 12.079

Review 4.  [Secondary open-angle glaucoma: pseudoexfoliative glaucoma, pigmentary glaucoma and neovascular glaucoma].

Authors:  Roman Greslechner; Horst Helbig; Detlev Spiegel
Journal:  Ophthalmologe       Date:  2022-04-01       Impact factor: 1.059

5.  Social determinants associated with loss of an eye in the United States using the All of Us nationwide database.

Authors:  Alison X Chan; Bharanidharan Radha Saseendrakumar; Daniel J Ozzello; Michelle Ting; Jin Sook Yoon; Catherine Y Liu; Bobby S Korn; Don O Kikkawa; Sally L Baxter
Journal:  Orbit       Date:  2021-12-30

Review 6.  Survey on the management of orbital and intraocular tumors among oculofacial surgeons in the Asia-Pacific region.

Authors:  Priscilla Xinhui Wang; Victor Teck Chang Koh; Katherine Lun; Gangadhara Sundar
Journal:  Int Ophthalmol       Date:  2013-10-02       Impact factor: 2.031

7.  Removal of the eye in a tertiary care center of China: a retrospective study on 573 cases in 20 years.

Authors:  Ying Zhang; Mao-Nian Zhang; Xin Wang; Xiao-Fei Chen
Journal:  Int J Ophthalmol       Date:  2015-10-18       Impact factor: 1.779

8.  Evisceration in the modern age.

Authors:  Laura T Phan; Thomas N Hwang; Timothy J McCulley
Journal:  Middle East Afr J Ophthalmol       Date:  2012-01

Review 9.  Visual system plasticity in mammals: the story of monocular enucleation-induced vision loss.

Authors:  Julie Nys; Isabelle Scheyltjens; Lutgarde Arckens
Journal:  Front Syst Neurosci       Date:  2015-04-28

10.  Fifteen-year trends in indications for enucleation from a tertiary care center in South India.

Authors:  Sabyasachi Sengupta; Subramanian Krishnakumar; Jyotirmay Biswas; Lingam Gopal; Vikas Khetan
Journal:  Indian J Ophthalmol       Date:  2012 May-Jun       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.